» Articles » PMID: 29409254

The Role of Bone Marrow Edema on Osteochondral Lesions of the Talus

Overview
Journal Foot Ankle Surg
Specialty Orthopedics
Date 2018 Feb 8
PMID 29409254
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To assess the functional and radiological outcomes after arthroscopic talus autologous matrix-induced chondrogenesis (AT-AMIC) in 2 groups: patients with and without bone marrow edema (BME).

Methods: Thirty-seven patients of which 24 without edema (GNE) and 13 with edema (GE) were evaluated. All patients were treated with AT-AMIC repair for symptomatic osteochondral talar lesion. Clinical and radiological parameters were evaluated with VAS score for pain, AOFAS and SF-12 at T (preoperatively), T (6 months), T (12 months), T (24 months) and MRI and CT-scan at T, T, T and T.

Results: No patients were lost to the final follow-up. In both groups we found a significant difference for clinical and radiological parameters with ANOVA for repeated measures through four time points (p<0.001). In GNE, AOFAS improved significantly at each follow-up (p<0.05); while CT and MRI showed a significant reduction in lesion size between T and T and T and T (p<0.05). In GE, AOFAS improved significantly between T and T and T and T (p<0.05); lesion size, measured with CT, decreased between T and T (p<0.05), while with MRI the lesion showed a reduction at each follow-up (p<0.05). Lesion size was significantly higher both in MRI and CT in GE compared to GNE (p<0.05). In GNE no patients presented edema at T while in GE only 23.08% of the patients presented edema at T CONCLUSIONS: The study revealed that osteochondral lesions of the talus were characterized by bigger size both in MRI and CT in patients with edema. We conclude that AT-AMIC can be considered a safe and reliable procedure that allows effective healing, regardless of edema and more than half of patients did not present edema six months after surgery.

Citing Articles

Application of extracorporeal shockwave to regulate subchondral bone homeostasis through tumor necrosis factor-α/hypoxia-inducible factor-1α/vascular endothelial growth factor signaling pathway in treatment of talus bone marrow edema.

Wang Z, Wang Z, Wu F Medicine (Baltimore). 2024; 103(45):e40228.

PMID: 39533623 PMC: 11557035. DOI: 10.1097/MD.0000000000040228.


Reporting of Morphology, Location, and Size in the Treatment of Osteochondral Lesions of the Talus in 11,785 Patients: A Systematic Review and Meta-Analysis.

van Diepen P, Smithuis F, Hollander J, Dahmen J, Emanuel K, Stufkens S Cartilage. 2024; :19476035241229026.

PMID: 38366391 PMC: 11569679. DOI: 10.1177/19476035241229026.


Simultaneous Treatment of Osteochondral Lesion Does Not Affect the Mid- to Long-Term Outcomes of Ligament Repair for Acute Ankle Sprain: A Retrospective Comparative Study with a 3-11-Year Follow-up.

Du M, Su T, Jiang Y, Jiao C, Guo Q, Hu Y Front Surg. 2022; 9:816669.

PMID: 35615649 PMC: 9124844. DOI: 10.3389/fsurg.2022.816669.


Correlation of Postoperative Imaging With MRI and Clinical Outcome After Cartilage Repair of the Ankle: A Systematic Review and Meta-analysis.

Waltenspul M, Zindel C, Altorfer F, Wirth S, Ackermann J Foot Ankle Orthop. 2022; 7(2):24730114221092021.

PMID: 35520475 PMC: 9067057. DOI: 10.1177/24730114221092021.


Retrograde Drilling for Osteochondral Lesion of the Talus in Juvenile Patients.

Ikuta Y, Nakasa T, Ota Y, Kanemitsu M, Sumii J, Nekomoto A Foot Ankle Orthop. 2022; 5(2):2473011420916139.

PMID: 35097373 PMC: 8697134. DOI: 10.1177/2473011420916139.